ProPhase Labs, Inc.
PRPH
$0.3513
$0.041113.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 57.91% | -62.39% | -81.28% | -81.17% | -127.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.91% | -62.39% | -81.28% | -81.17% | -127.04% |
| Cost of Revenue | -57.63% | -45.16% | -56.42% | -53.69% | -120.51% |
| Gross Profit | 124.71% | -107.09% | -107.38% | -104.12% | -133.14% |
| SG&A Expenses | 121.63% | -7.22% | -27.42% | -8.50% | -45.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 138.89% | -25.33% | -42.37% | -35.25% | -81.21% |
| Operating Income | -32.92% | -22.52% | -68.03% | -1,048.34% | -115.30% |
| Income Before Tax | -41.74% | -34.05% | -71.75% | -1,665.78% | -117.06% |
| Income Tax Expenses | 599.52% | -52.55% | -55.16% | -18,428.57% | -6.16% |
| Earnings from Continuing Operations | -265.55% | -28.13% | -78.87% | -1,239.09% | -241.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -292.63% | -28.13% | -78.87% | -1,239.09% | -258.06% |
| EBIT | -32.92% | -22.52% | -68.03% | -1,048.34% | -115.30% |
| EBITDA | -50.61% | -18.48% | -87.56% | -405.12% | -124.40% |
| EPS Basic | -217.49% | -15.34% | -59.55% | -1,158.54% | -232.76% |
| Normalized Basic EPS | 0.72% | -20.66% | -53.21% | -1,556.67% | -116.72% |
| EPS Diluted | -217.05% | -16.67% | -61.61% | -1,167.07% | -232.54% |
| Normalized Diluted EPS | 0.72% | -20.66% | -53.21% | -1,668.72% | -116.72% |
| Average Basic Shares Outstanding | 18.92% | 11.09% | 12.13% | 7.74% | 5.93% |
| Average Diluted Shares Outstanding | 18.92% | 11.09% | 12.13% | -0.09% | 5.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |